From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.
June 27, 2000
NEW YORK, June 27 (Praxis Press) Heparins have been shown to be effective and safe in the treatment of deep vein thrombosis, but the use of this treatment on an outpatient versus an inpatient basis has not been compared. To compare the two treatment locales, Boccalon and colleagues conducted a randomized, comparative, multicenter trial and evaluated the clinical outcomes and treatment costs (see paper). The researchers examined 201 patients with proximal deep vein thrombosis and administered low